No Bids for a Niche Lens: One Small Corner of a EUR 35 Million Italian Ophthalmology Tender Comes Up Empty

Standfirst

Azienda USL della Romagna, a major regional health authority in Emilia Romagna, sought a supplier for a specialised intraocular lens used in cataract and aphakia surgery, one of 77 lots in a EUR 35 537 995.20 programme covering single use ophthalmology devices. Not a single tender was submitted for this specific lens and the health authority has formally closed that lot without a winner.

Introduction

Eye surgery depends on a remarkably specific supply chain, one where a hospital's ability to treat a particular condition can hinge on a single, narrowly defined product being available from a single qualified manufacturer. Azienda USL della Romagna, the public health authority serving a large part of Italy's Emilia Romagna region, discovered exactly that limitation when it went looking for suppliers of a specialised intraocular lens.

The lens in question, a monofocal PMMA lens designed for aphakia correction with iris fixation, used when a patient's eye lacks its natural lens and standard capsular support for a replacement is not available, is one small piece of a much larger tender covering 77 separate lots of ophthalmology supplies. For this particular lot, the market simply did not respond.

Why This Contract Matters

Iris fixated intraocular lenses serve a specific, clinically important purpose: they give surgeons an option for patients who need lens replacement but lack the anatomical support structures a standard implant would normally rely on. A public health authority unable to source this specific device through its standard procurement channel faces a real, if narrow, gap in its surgical supply chain.

The notice's broader context also matters. This is one lot within a 77 lot, EUR 35.5 million programme meant to secure Azienda USL della Romagna's ophthalmology supply needs across the board. A single failed lot within a programme this large is a useful reminder that even comprehensive, well resourced procurement exercises can leave gaps in highly specialised product categories.

Contract Timeline

• Procedure type: Open procedure under Directive 2014/24/EU
• Competition for Lot 24 formally closed with no winner chosen
• Notice dispatched to the Publications Office: 10 August 2026
• Published in the Official Journal, OJ S 153/2026: 11 August 2026
• This notice is published as version 06, indicating multiple prior updates to the overall programme's results

Contract Overview

Azienda USL della Romagna ran an open procedure above EU thresholds to conclude a framework agreement with multiple economic operators for the supply of medical devices, single-use surgical instruments and panoramic systems for ophthalmology procedures, across the authority's hospital facilities. The overall programme spans 77 separately awardable lots, evaluated either on best price quality ratio, for a specified list of lots including this one or on lowest price for the remainder. This particular result notice addresses Lot 24, a monofocal PMMA lens for aphakia with iris fixation, estimated at EUR 541 500.00. No tenders were received and the authority has formally closed the lot without awarding it.

Key Contract Details

Project Scope

Lot 24 covers a single, specifically defined product: a monofocal intraocular lens made of PMMA, polymethyl methacrylate, a rigid plastic material long used in lens implants, designed for aphakia correction with iris fixation, meaning the lens is secured to the iris rather than relying on the eye's natural capsular support structure. This is a specialised device used in particular surgical circumstances rather than routine cataract replacement.

The broader OCULISTICA MONOUSO ED2 programme covers medical devices, single use surgical instruments with accessories and panoramic imaging systems for ophthalmology procedures across Azienda USL della Romagna's hospital network, split into 77 lots to allow specialised suppliers to bid on individual product categories rather than requiring a single supplier to cover the full range.

About the Contracting Authority

Azienda USL della Romagna is a body governed by public law controlled by a regional authority, active in the health sector, based in Ravenna. It is one of the larger integrated regional health authorities in Italy's Emilia-Romagna region, managing hospital and health services across a wide territorial area that includes Ravenna and neighbouring provinces.

About the Organisations Involved

Azienda USL della Romagna

As covered above, Azienda USL della Romagna is the buyer behind this tender, with its contact point listed as Annalisa Fabbri.

TAR Emilia Romagna - Bologna

The Regional Administrative Court for Emilia-Romagna, based in Bologna, is named as the review organisation for this contract, the standard venue in Italy for challenges to regional public procurement decisions. The notice defers specific review deadline information to the tender's own technical specifications document rather than stating it directly.

ANAC Autorità Nazionale Anticorruzione

Italy's National Anti-Corruption Authority is listed in the notice in the role of procurement service provider, reflecting ANAC's broader function supporting and overseeing public procurement processes across Italian contracting authorities, alongside its core anti-corruption mandate.

Procurement Analysis

The overall OCULISTICA MONOUSO ED2 programme was structured as an open procedure to establish a framework agreement with multiple suppliers across 77 lots, allowing the health authority to secure a broad range of ophthalmology products from specialised suppliers in each category. Lot 24 specifically was designated for evaluation under best price quality ratio criteria, weighting technical merit at 70 points against an economic score of 30 points, reflecting the clinical importance of getting a device like this right, not simply choosing the cheapest option.

The complete absence of any tender for this lot is the central fact of this result. The reason recorded is the most direct possible: no tenders, requests to participate or projects were received. For a highly specialised device like an iris fixated aphakia lens, a product used in a relatively narrow set of surgical circumstances, a limited or even absent supplier response is more plausible than it would be for standard cataract lenses or routine ophthalmology disposables, though the notice does not explain the underlying market conditions behind the non-response.

One inconsistency worth flagging: the overall procedure description explicitly frames this tender as being for the conclusion of a framework agreement with multiple economic operators, yet the specific technique field recorded against Lot 24 states no framework agreement applies. Given the lot received no bids at all, this discrepancy has no practical consequence for this particular result, but it is worth noting as an example of how lot level technical fields do not always align perfectly with a programme's overall stated structure.

Additional Procurement Facts

• Lot 24 is confirmed as not financed with EU funds and as not covered by the Government Procurement Agreement.
• This notice is published as version 06, indicating the overall 77 lot programme's results have been updated or corrected multiple times since the original publication.
• No tenders were recorded as submitted electronically, from SMEs, as verified inadmissible or as inadmissible due to abnormally low pricing, confirming a complete absence of market response for this lot specifically.

Market and Industry Perspective

Intraocular lens manufacturing spans a wide spectrum from high volume standard cataract lenses, produced by several major global ophthalmic device manufacturers, to niche specialised variants like iris fixated aphakia lenses, which serve a smaller surgical population and may be produced by only a handful of specialist manufacturers globally. A zero bid outcome for a lot this specific is consistent with a market where very few suppliers carry this exact product configuration, particularly if existing suppliers were already committed elsewhere or judged the lot's terms unattractive relative to their broader business.

Given the overall programme's scale, 77 lots and over EUR 35 million, it is likely that many of the other lots in this tender, covering more commonly used ophthalmology devices, attracted stronger competitive interest, making this failed lot a notable but likely isolated gap within an otherwise substantial and successful procurement exercise.

Economic Significance

At EUR 541 500.00, Lot 24 represents a modest fraction of the overall EUR 35.5 million programme, but its failure to attract any bid leaves Azienda USL della Romagna without a secured supply channel for this specific device category, a gap that matters clinically even if it is small in overall budgetary terms.

Future Procurement Opportunities

Health authorities facing a failed lot of this kind typically have the option to relaunch the tender for that specific product, potentially with revised terms, pricing assumptions or specification adjustments designed to attract supplier interest the second time. Given the specialised nature of this device, a retender with direct outreach to known manufacturers of iris fixated lenses may prove more effective than a further open, general publication.

Opportunities for Suppliers

Manufacturers and distributors of specialised intraocular lenses, particularly iris fixated aphakia correction lenses, should treat this notice as a direct signal of unmet demand from a major Italian regional health authority. With no competing bids to contend with, a supplier able to meet the lot's technical requirements would likely find a considerably more favourable competitive position than is typical in Italy's broader, more heavily contested ophthalmic device market.

What Businesses Should Watch

• Whether Azienda USL della Romagna relaunches Lot 24 as a standalone retender and what terms accompany a second attempt.
• The outcomes of the remaining 76 lots within the broader OCULISTICA MONOUSO ED2 programme, not addressed in this notice.
• Whether similar niche ophthalmology device lots in other Italian regional health authority tenders show comparable non-response patterns.

ItalyTenders.com Procurement Intelligence

This notice is a useful reminder that even within large, well structured procurement programmes covering dozens of lots, individual highly specialised product categories can still fail to attract any supplier interest at all. The lesson for health system procurement teams is that niche clinical devices, serving small patient populations with specific anatomical or surgical needs, often warrant a different sourcing approach than routine, high volume medical supplies, potentially including direct market engagement with known specialist manufacturers before or alongside formal open tendering.

For suppliers in the ophthalmic device space, a null result like this one is a clear, low risk signal of where genuine unmet demand exists. Unlike heavily contested standard lens categories, a lot that failed to attract even a single bid effectively guarantees a supplier meeting the technical specification a clear path to award on any retender, a rare position of leverage in public healthcare procurement.

More broadly, this notice's sixth version status is a reminder that large, multi-lot health procurement programmes are living documents, updated repeatedly as individual lots are resolved, contested or in this case, left unfilled, over an extended period. Businesses tracking opportunities within programmes of this scale should expect to monitor them well beyond the initial publication, since outcomes for different lots can surface at very different times.

Supplier Takeaways

• This lot for a specialised iris fixated aphakia lens received zero bids, indicating either a very narrow qualified supplier base or unattractive tender terms for this specific device category.
• The lot sat within a much larger EUR 35.5 million, 77 lot ophthalmology supplies programme, of which only this one lot's outcome is addressed in this notice.
• Award criteria for this lot weighted technical quality heavily, at 70 points against 30 for price, reflecting the clinical specificity of the device.
• A retender of this specific lot, potentially with revised terms or direct supplier outreach, is a realistic next step worth monitoring.
• Specialist manufacturers of this lens type face limited competition if and when this lot is relaunched.

Key Takeaways

• Azienda USL della Romagna received zero tenders for Lot 24 of its OCULISTICA MONOUSO ED2 programme, covering a specialised monofocal PMMA lens for aphakia with iris fixation.
• The lot has been formally closed with no winner chosen, citing the complete absence of any submissions.
• The lot sat within a much larger EUR 35 537 995.20 programme covering 77 lots of ophthalmology supplies.
• Award criteria for this lot weighted technical quality at 70 points against a 30 point economic score.
• This notice does not address the outcomes of the programme's other 76 lots.
• The notice is published as its sixth version, reflecting multiple updates to this large programme's results over time.

Conclusion

Somewhere in the gap between a 77 lot tender's overall success and one small, empty result sits a genuinely useful signal for the ophthalmic device market. Azienda USL della Romagna secured supply for the overwhelming majority of its ophthalmology device needs through this programme, but for one narrowly specialised lens, the market had nothing to offer. For the right supplier, that gap is an opportunity waiting to be filled.

Source: Tenders Electronic Daily (TED), Contract Award Notice 556039-2026, Official Journal of the European Union, OJ S 153/2026, published on 11 August 2026.